Teva Pharma (TEVA) PT Raised to $8 at Piper Sandler
Tweet
Share
E-mailGet Alerts TEVA Hot Sheet
Price: $36.46 -0.84%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Sandler analyst David Amsellem raised the price target on Teva Pharma (NYSE: TEVA) to $8.00 (from $7.00) while maintaining a Underweight rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- Maxis Bhd (MAXIS:MK) (MAXSF) PT Raised to MYR3.82 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
